Fortrea Holdings (FTRE) Interest Expenses (2022 - 2026)
Fortrea Holdings (FTRE) posted Interest Expenses of $23.4 million for Q1 2026, down 50.0% on a QoQ basis from $46.8 million in Q4 2025, and down 31.58% year-over-year from $34.2 million in Q1 2025.
Fortrea Holdings (FTRE) Interest Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings' Interest Expenses history runs 5 years deep, the most recent figure standing at $23.4 million for Q1 2026.
- Quarterly Interest Expenses fell 31.58% year-over-year to $23.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.5 million (down 8.96% YoY) and the FY2025 annual result came in at $48.0 million, down 56.2% from the prior year.
- Interest Expenses was $23.4 million for Q1 2026 at Fortrea Holdings, down from $46.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $60.1 million in Q2 2023 and bottomed at $100000.0 in Q1 2023.
- A 5-year average of $34.8 million and a median of $32.8 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses jumped 50000.0% — and 2025, when it plunged 75.81%.
- Fortrea Holdings' Interest Expenses stood at $50.3 million in 2022, then plunged by 40.16% to $30.1 million in 2023, then slumped by 62.46% to $11.3 million in 2024, then jumped by 314.16% to $46.8 million in 2025, then plunged by 50.0% to $23.4 million in 2026.
- Business Quant data shows FTRE's Interest Expenses at $23.4 million in Q1 2026, $46.8 million in Q4 2025, and $27.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 23.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.40 Mn |
| Mar 31, 2026 | 23.40 Mn |
| Dec 31, 2025 | 46.80 Mn |
| Dec 31, 2025 | 46.80 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Sep 30, 2025 | 27.90 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 34.20 Mn |
| Mar 31, 2025 | 34.20 Mn |
| Dec 31, 2024 | 11.30 Mn |
| Dec 31, 2024 | 11.30 Mn |
| Sep 30, 2024 | 31.50 Mn |
| Sep 30, 2024 | 31.50 Mn |
| Jun 30, 2024 | 49.60 Mn |
| Jun 30, 2024 | 49.60 Mn |
| Mar 31, 2024 | 50.10 Mn |
| Mar 31, 2024 | 50.10 Mn |
| Dec 31, 2023 | 30.10 Mn |
| Dec 31, 2023 | 30.10 Mn |